Feb 27, 2026 09:31AM
Feb 24, 2026 04:14PM
Jan 12, 2026 09:30AM
Jan 12, 2026 07:20AM
Jan 12, 2026 07:06AM
Jan 9, 2026 04:57AM
Jan 8, 2026 04:07PM Jazz Pharmaceuticals names Thomas Riga as Chief Business Officer
Jan 8, 2026 08:49AM
Jan 7, 2026 04:13AM
Jan 6, 2026 02:18PM
Jan 6, 2026 01:33PM
Jan 6, 2026 11:46AM
Dec 10, 2025 07:30AM
Dec 5, 2025 09:01AM Jazz Pharmaceuticals to present Epidiolex data at epilepsy conference
Nov 24, 2025 05:53AM
Nov 18, 2025 05:00AM
Nov 18, 2025 04:59AM
Nov 18, 2025 04:11AM
Nov 17, 2025 11:04AM
Nov 12, 2025 05:00AM
Nov 11, 2025 07:45AM Jazz Pharmaceuticals presents Modeyso data at neuro-oncology meeting
Nov 5, 2025 04:33PM
Oct 22, 2025 03:19PM
Oct 3, 2025 08:05AM
Oct 2, 2025 03:33PM
Sep 23, 2025 04:04PM
Sep 22, 2025 07:45AM
Sep 15, 2025 08:29AM Piper Sandler Reiterates Overweight Rating on Jazz Pharmaceuticals (JAZZ)
Sep 11, 2025 08:18AM
Sep 9, 2025 07:45AM
Aug 28, 2025 09:25AM
Aug 28, 2025 08:54AM
Aug 28, 2025 07:36AM
Aug 20, 2025 07:30AM
Aug 14, 2025 06:14AM Jazz Pharmaceuticals (JAZZ) PT Raised to $225 at BofA Securities
Aug 6, 2025 02:24PM
Aug 5, 2025 04:29PM
Jul 15, 2025 04:05AM
Jul 10, 2025 07:30AM
Jul 1, 2025 08:32AM
Jun 11, 2025 07:15AM
Jun 10, 2025 07:05AM Jazz Pharmaceuticals (JAZZ) Reports Zepzelca and Atezolizumab Combination Granted FDA Priority Review
Jun 9, 2025 06:27PM
Jun 3, 2025 08:19AM
Jun 2, 2025 04:05PM
Jun 2, 2025 12:38PM
May 25, 2025 03:00PM
May 6, 2025 04:30PM
Apr 22, 2025 09:34AM TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Apr 21, 2025 04:05PM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All